Sugi Predict

Sugi Predict / Compounds / SCHEMBL2073418

SCHEMBL2073418

SCHEMBL2073418

O=[N+]([O-])C=Cc1cccc(Cl)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 13/20 1.00
▸ VCP P55072 1/20 0.64
▸ MAOA P21397 2/20 0.63
▸ MAOB P27338 2/20 0.63
▸ TERT O14746 1/20 0.63
▸ TLR4 O00206 2/20 0.57
▸ TLR2 O60603 2/20 0.57
▸ HSP90AA1 P07900 1/20 0.55
▸ CYP1A2 P05177 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ ABL1 P00519 1/20 0.51
▸ EGFR P00533 1/20 0.51
▸ ABL2 P42684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29925064 1.00 FBP1 (1.00) FBP1VCPMAOAMAOBTERT
SCHEMBL30914651 1.00 FBP1 (1.00) FBP1VCPMAOAMAOBTERT
SCHEMBL1937312 1.00 FBP1 (1.00) FBP1VCPMAOAMAOBTERT
SCHEMBL5924031 0.80 FBP1 (0.67) FBP1VCPMAOAMAOBTERT
SCHEMBL5924030 0.80 FBP1 (0.67) FBP1VCPMAOAMAOBTERT
SCHEMBL5211010 0.79 FBP1 (0.85) FBP1VCPMAOAMAOBTERT
SCHEMBL6810598 0.78 TERT (1.00) FBP1VCPMAOAMAOBTERT
SCHEMBL6810602 0.78 TERT (1.00) FBP1VCPMAOAMAOBTERT
SCHEMBL527535 0.78 FBP1 (1.00) FBP1VCPMAOAMAOBTLR4
SCHEMBL527534 0.78 FBP1 (1.00) FBP1VCPMAOAMAOBTLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104277072-B A kind of preparation method of (E)-2-aryl vinyl phosphate derivatives JIANGSU CHINASUN SPECIALTY PRODUCTS CO.,LTD. (CN) 2016-04-13 — — CN claimed
EP-2982368-A1 Small molecule compounds displacing focal adhesion core components Universität Konstanz (DE) 2016-02-10 — — EP claimed
CN-104277072-A Method for preparing (E)-2-aryl vinyl phosphonate derivatives CHINASUN SPECIALTY PRODUCTS CO LTD 2015-01-14 — — CN claimed
CN-111217707-B Preparation method of beta-trans-nitroolefin 西北师范大学 2022-09-16 — — CN disclosed
CN-113509959-A Preparation method of hollow mesoporous nano silicon spheres for packaging chiral catalyst, product and application thereof 重庆邮电大学 2021-10-19 — — CN disclosed
CN-111217707-A preparation method of β -trans-nitroolefin 西北师范大学 2020-06-02 — — CN disclosed
EP-2970215-B1 PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBVIE DEUTSCHLAND (DE) 2019-04-17 — — EP disclosed
CN-107011175-B Method for synthesizing chiral gamma-nitrophenol compound 浙江工业大学 2019-02-01 — — CN disclosed
EP-3129380-B1 SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE DERIVATIVES AND THEIR USE AS MDM2-P53 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2018-11-28 — — EP disclosed
US-10138251-B2 Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-11-27 — — US disclosed
US-20180291030-A1 NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2018-10-11 — — US disclosed
EP-1668014-A2 FUSED HETEROCYCLIC COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-14 — — EP disclosed
US-20050119295-A1 Fused heterocyclic compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2005-06-02 — — US disclosed
WO-2005040169-A2 FUSED HETEROCYCLIC COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-05-06 — — WO disclosed
US-5248677-A Nervous system disorders or antidepressants ABBOTT LABORATORIES (US) 1993-09-28 — — US disclosed
US-5180733-A Antidepressants or nervous systen disorders ABBOTT LABORATORIES (US) 1993-01-19 — — US disclosed
EP-0461353-A1 Biogenic amine uptake inhibitors ABBOTT LABORATORIES (US) 1991-12-18 — — EP disclosed
EP-0096142-B1 MICROBICIDAL SULFONYL PYRROLE CIBA-GEIGY AG (CH) 1989-01-18 — — EP disclosed
US-4085165-A ISOCYANATE PREPOLYMER, VINYL COMPOUND, POLYAMINE OR POLYETHER CURING AGENT BRIDGESTONE TIRE CO., LTD. (JA) 1978-04-18 — — US disclosed
US-3931220-A FUNGICIDE, BACTERICIDE BAYER AKTIENGESELLSCHAFT (DT) 1976-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180291030-A1 NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS TP53, MDM2, FOXM1 FBP1 2741/4885VCP 3278/4885MAOA 1978/4885
US-10138251-B2 Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors TP53, MDM2, FOXM1 FBP1 2821/4885VCP 3588/4885MAOA 1879/4885
US-20050119295-A1 Fused heterocyclic compounds TPH1, HTR3A, HTR3B FBP1 1093/4885VCP 4173/4885MAOA 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.